Putting the Record Straight on Aprotinin as Safe and Effective: Results from a Mixed Treatment Meta-Analysis of Trials of Aprotinin
This mixed treatment comparisons meta-analysis demonstrates no increased mortality risk with aprotinin versus other antifibrinolytic agents.
